Search for: "Novartis Pharmaceuticals Corporation"
Results 21 - 40
of 216
Sort by Relevance
|
Sort by Date
30 Jan 2020, 10:49 am
Correctional facilities operators Management and Training Corporation, Cornell Companies, Inc. [read post]
24 Jan 2020, 10:24 am
Also tagged in this scheme were Novartis, Dendreon, Onyx, Questcor, and Bayer. [read post]
19 Dec 2019, 12:23 pm
As an aside, one wonders why there has been no FDA action regarding this Gilenya birth defects issue and why there has been no "Dear Doctor Letter" about pregnant women using Gilenya sent out by Novartis Pharmaceuticals Corporation in the US as of this date (i.e., December 19, 2019). [read post]
7 Dec 2018, 2:23 pm
The outcome was reversal; Novartis wins:Novartis Pharmaceuticals Corporation and NovartisAG (collectively, Novartis) appeal the district court’sdecision to invalidate U.S. [read post]
16 May 2018, 7:17 pm
The document detailed sums in the hundreds of thousands of dollars paid to Cohen by the pharmaceutical company Novartis, the telecommunications giant A.T. [read post]
11 May 2018, 8:59 am
We got word that a couple weeks ago, the Swiss pharmaceutical giant, Novartis, was about to change its company profile page! [read post]
6 Mar 2018, 2:10 pm
In closing this article, I will point out that as of today, nearly five years after the actions taken by Novartis Pharmaceuticals Canada Inc., in the US there still has not been any "Dear Doctor" letter nor any Tasigna drug label change made by Novartis Pharmaceuticals Corporation similar to what was done in Canada during April 2013. [read post]
6 Mar 2018, 2:10 pm
In closing this article, I will point out that in the US there still has not been any "Dear Doctor" letter sent nor any Tasigna drug label change made by Novartis Pharmaceuticals Corporation regarding atherosclerosis, despite the actions taken by its Canadian counterpart during April 2013. [read post]
27 Feb 2018, 9:12 am
We point out that there was no similar "Dear Doctor" letter sent in the US by Novartis Pharmaceuticals Corporation in 2013, nor was any similar Tasigna drug label change made by Novartis in the US back then. [read post]
7 Feb 2018, 8:39 am
What’s more alarming, the drug’s manufacturer, Novartis Pharmaceuticals Corporation, may have known about those risks and failed to disclose them to you. [read post]
17 Jan 2018, 1:37 pm
Novartis Pharmaceuticals Corporation, S233898).La prescription "off-label" d'un produit pharmaceutique est admise. [read post]
17 Jan 2018, 1:29 pm
Novartis Pharmaceuticals Corporation, S233898).Quand elles statuent en diversité, les cours fédérales veilleront à appliquer le droit des états dans sa teneur objective, sans chercher à créer de nouvelles théories juridiques. [read post]
17 Jan 2018, 1:25 pm
Novartis Pharmaceuticals Corporation, S233898).Le devoir de diligence est une des conditions centrales de l'obligation de réparer un dommage en responsabilité civile. [read post]
17 Jan 2018, 1:16 pm
Novartis Pharmaceuticals Corporation, S233898).Prévisibilité du dommage en responsabilité civile et contractuelle (droit californien) :Face à la question de savoir si un défendeur répond envers un lésé, le droit californien accorde une importance essentielle à la notion de prévisibilité. [read post]
14 Jan 2018, 6:34 am
Novartis Pharmaceuticals Corporation, S233898).Exigences en matière d'étiquetages et notices, ici de médicaments et de dispositifs médicaux Le droit des états, ici californien, protège substantiellement les consommateurs de médicaments des dangers posés par des étiquetages et des notices faux, trompeurs ou inadéquats. [read post]
14 Jan 2018, 4:00 am
Novartis Pharmaceuticals Corporation, S233898).Le producteur d'un carburant vendu en gros n'est redevable d'aucun devoir d'aviser des risques envers le consommateur final, lorsque le producteur a donné un avis adéquat au distributeur, auquel revient les tâches de conditionner et d'écouler le produit. [read post]
13 Jan 2018, 8:00 pm
Novartis Pharmaceuticals Corporation, S233898).Responsabilité civile et contractuelle (droit californien), déclaration inexacte ("misrepresentation") :En droit californien, une action en dommages-intérêts fondée sur une déclaration inexacte peut être déposée contre d'autres défendeurs que le seul fabricant du produit. [read post]
11 Dec 2017, 7:39 am
Novartis Pharmaceuticals Corporation, 4-17-cv-04405 (CAND December 7, 2017, Order) (Gilliam, USDJ) [read post]
21 Nov 2017, 2:40 pm
We recommend that the FDA and [Novartis Pharmaceuticals Corporation] the manufacturer [of Entresto] more clearly communicate the full risk of hypotension, including appropriate steps for monitoring patients, and examine whether a more gradual escalation of dose to the recommended level would reduce the risk. [read post]
16 Sep 2016, 4:07 am
In the Actavis case, the applicants similarly argued that Orion’s agreement to supply finished product, or active pharmaceutical ingredients, to Novartis meant that the arrangement did not constitute an exclusive licence. [read post]
